Anne Altmeyer
Director/Board Member at CORBUS PHARMACEUTICALS HOLDINGS, INC.
Net worth: - $ as of 2024-04-29
Profile
Anne Altmeyer is currently the Chief Executive Officer & Director at TigaTx, Inc. and an Independent Director at Corbus Pharmaceuticals Holdings, Inc. Previously, she held the position of Vice President-Business Development & Licensing at Baxalta, Inc. from 2015 to 2016.
From 2019 to 2021, she served as the Chief Business Officer at Sigilon Therapeutics, Inc. Prior to that, she was the Chief Business Officer at Adicet Bio, Inc. from 2016 to 2019.
Dr. Altmeyer also worked at Novartis Corp.
as the Vice President-Business Development & Licensing from 2004 to 2015.
She holds a graduate degree from the University of Medicine & Dentistry of New Jersey, a doctorate degree from the University of Strasbourg, and an MBA from Rutgers University-New Brunswick.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-05-15 | 0 ( -.--% ) | - $ | 2024-04-29 |
Anne Altmeyer active positions
| Companies | Position | Start |
|---|---|---|
| CORBUS PHARMACEUTICALS HOLDINGS, INC. | Director/Board Member | 2022-09-19 |
TigaTx, Inc.
 TigaTx, Inc. BiotechnologyHealth Technology TigaTx, Inc. is a biotechnology company that focuses on developing first-in-class, engineered IGA as neutrophil engagers to fight cancer. The company is based in Boston, MA. TigaTx is backed by excellent investors and has an accomplished scientific advisory board. It was founded by Jeanette Leusen and the CEO is Anne Altmeyer. | Chief Executive Officer | 2020-12-31 |
Former positions of Anne Altmeyer
| Companies | Position | End |
|---|---|---|
| SIGILON THERAPEUTICS, INC. | Corporate Officer/Principal | 2020-12-31 |
| ADICET BIO, INC. | Corporate Officer/Principal | 2018-12-31 |
| BAXALTA INC | Corporate Officer/Principal | 2015-12-31 |
Novartis Corp.
 Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Corporate Officer/Principal | 2015-07-31 |
Training of Anne Altmeyer
| University of Strasbourg | Doctorate Degree |
| Rutgers University-New Brunswick | Masters Business Admin |
| University of Medicine & Dentistry of New Jersey | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| SIGILON THERAPEUTICS, INC. | Health Technology |
| ADICET BIO, INC. | Health Technology |
| CORBUS PHARMACEUTICALS HOLDINGS, INC. | Health Technology |
| Private companies | 3 |
|---|---|
Baxalta, Inc.
 Baxalta, Inc. BiotechnologyHealth Technology Baxalta, Inc. engages in the research, development, and manufacture of biopharmaceutical products. Its portfolio includes treatments for hemophilia, bleeding disorders, immune deficiencies, alpha-1 antitrypsin deficiency, burns, and shock. The company was founded on March 13, 2015 and is headquartered in Chicago, IL. | Health Technology |
TigaTx, Inc.
TigaTx, Inc. BiotechnologyHealth Technology TigaTx, Inc. is a biotechnology company that focuses on developing first-in-class, engineered IGA as neutrophil engagers to fight cancer. The company is based in Boston, MA. TigaTx is backed by excellent investors and has an accomplished scientific advisory board. It was founded by Jeanette Leusen and the CEO is Anne Altmeyer. | Health Technology |
Novartis Corp.
Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Health Technology |
- Stock Market
- Insiders
- Anne Altmeyer
